Marker Therapeutics, Inc.
(NASDAQ : TPIV)

( )
TPIV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Consumer Services » Other Consumer Services
symbolcompany%chnglast%shortavg$volume
EBAYeBay Inc.
-2.26%28.961.7%$438.52m
EXPEExpedia, Inc.
-1.44%122.256.8%$264.34m
TRIPTripAdvisor, Inc.
-1.00%62.6713.0%$174.89m
CTRPCtrip.com International Ltd Sponsored ADR
-2.22%25.554.3%$174.77m
EDUNew Oriental Education & Technology Group, Inc. Sponsored ADR
-0.33%57.211.3%$146.47m
WTWWeight Watchers International, Inc.
-5.03%47.8014.7%$113.32m
HRBH&R Block, Inc.
-1.25%28.3711.2%$72.11m
PLNTPlanet Fitness Inc Class A
-7.11%51.0811.5%$64.48m
SERVServiceMaster Global Holdings Inc
-0.09%42.484.7%$63.35m
ROLRollins, Inc.
-1.63%60.374.0%$61.05m
SCIService Corporation International
-0.45%44.615.2%$56.66m
LOPEGrand Canyon Education, Inc.
-1.12%127.032.0%$54.04m
CHGGChegg, Inc.
-3.36%26.1816.5%$39.82m
NTRINutrisystem, Inc.
-1.48%36.523.7%$36.71m
BIDSotheby's Class A
-2.08%40.1117.8%$23.34m

Company Profile

Marker Therapeutics, Inc. is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Jacksonville, FL.